cerrar
Tagged with biotech

David Kershenobich Stalnikowitz – General Director, Instituto…
Considered one of the leading medical authorities in the country, David Kershenobich provides an overview about the new challenges faced by the…

Moon Eun-Sang – CEO, SillaJen – South Korea
SillaJen’s CEO shares his passion for his companies oncolytic vaccinia virus, and its potential to revolutionize the treatment of solid tumor…

Angie Kim – CEO, BMS Korea
After a lengthy career at Novartis, Angie Kim recently started working at BMS Korea to develop the affiliate. She discusses diversifying the…

South Korea: Round two of pharmaceutical export development…
On February second, the Korean Ministry of Health and Welfare announced the start of a second round of financing to the biopharmaceutical industry, as…

Nourreddine Loutichene – Executive Managing Director, MSD…
The executive managing director of a leading American healthcare provider offering an innovative range of products on the local Algerian market…

Dr Mayte Gil Borja, Director Latin America – Christian…
The genomic revolution represents a before and after in the field of medicine. Sistemas Genómicos has understood this back in 1998 and today is the…

Antonio Bouzada – President and Founder, Eriochem,…
The founder of Eriochem discusses his firm’s ambitious technology based on a competitive IP strategy and its exciting research on a radically new…

José Raúl Flores Fletes – General Director, BioGraft…
Biograft is the first private tissue bank in Mexico meeting the increasing demand for implants of human musculoskeletal tissue. The general director…

Shire Mexico – Dr. Raul Vivar, Head of Mexico / Central…
The general manager in charge of Mexico, Central America and the Caribbean is on board with the corporate mission of doubling Shire’s product sales…

Probiomed – Sandra Sanchez Y Oldenhage, General Director…
Probiomed wants to move to the next level. The recently appointed general director discusses her plans to grow the business and expand…

Amega Biotech- Francisco Molinari, CEO – Argentina
Francisco Molinari, CEO of Argentina’s most sophisticated biotech group discusses Argentina’s competitiveness in the global biosimilar market, the…

Venter Pharma – Jose Luis Martin, CEO – Spain
The CEO of Venter Pharma explains the challenges of bringing a diagnostic drug to the market, and how they hope to leverage the science behind their…
We use cookies to ensure that we give you the best experience on our site. For more info

See our Cookie Privacy Policy Here